PIN10 Cost-Utility Analysis Focused on Nosocomial Pneumonia Antimicrobial Therapy - Ceftolozane/Tazobactam Role in New Technologies Incorporation within Private Hospitals and HMOs in Brazil

Authors :: M.F. Almeida
T.J.B. Polis
S. Rodrigues
L. Chabrol Haas
H.E. Cavalcanti
P. de Mendonça Batista
Source :: Value in Health. 24:S107
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Cost–utility analysis
medicine.medical_specialty
Pneumonia
Emerging technologies
business.industry
Health Policy
Public Health, Environmental and Occupational Health
CEFTOLOZANE/TAZOBACTAM
medicine
Intensive care medicine
business
medicine.disease
Antimicrobial

Full Text Access

Tools